Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide.

Literature DB >> 23143669

Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide.

Massimo Franchini¹, Francesco Frattini, Silvia Crestani, Carlo Bonfanti.

Abstract

Entities: Chemical Disease

Mesh：

Year: 2013 PMID： 23143669 DOI： 10.1007/s11239-012-0840-5

Source DB: PubMed Journal: J Thromb Thrombolysis ISSN： 0929-5305 Impact factor: 2.300

× No keyword cloud information.

15 in total

1. Using thalidomide in a patient with epithelioid leiomyosarcoma and Osler-Weber-Rendu disease.

Authors: Ronald Kurstin
Journal: Oncology (Williston Park) Date: 2002-01 Impact factor: 2.990

2. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.

Authors: C Sabbà; M Gallitelli; G Palasciano
Journal: N Engl J Med Date: 2001-09-20 Impact factor: 91.245

3. Deep vein thrombosis induced by thalidomide to control epistaxis secondary to hereditary haemorrhagic telangiectasia.

Authors: Andrea Penaloza; Marie-Christiane Vekemans; Catherine Lambert; Cedric Hermans
Journal: Blood Coagul Fibrinolysis Date: 2011-10 Impact factor: 1.276

Review 4. Hereditary hemorrhagic telangiectasia: from molecular biology to patient care.

Authors: S Dupuis-Girod; S Bailly; H Plauchu
Journal: J Thromb Haemost Date: 2010-03-19 Impact factor: 5.824

5. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.

Authors: Sophie Dupuis-Girod; Isabelle Ginon; Jean-Christophe Saurin; Denis Marion; Elsa Guillot; Evelyne Decullier; Adeline Roux; Marie-France Carette; Brigitte Gilbert-Dussardier; Pierre-Yves Hatron; Pascal Lacombe; Bernard Lorcerie; Sophie Rivière; Romain Corre; Sophie Giraud; Sabine Bailly; Gilles Paintaud; David Ternant; Pierre-Jean Valette; Henri Plauchu; Frédéric Faure
Journal: JAMA Date: 2012-03-07 Impact factor: 56.272

Review 6. Hereditary haemorrhagic telangiectasia.

Authors: A A Sharathkumar; A Shapiro
Journal: Haemophilia Date: 2008-11 Impact factor: 4.287

Review 7. A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT).

Authors: Roberto Zarrabeitia; Virginia Albiñana; Matilde Salcedo; B Señaris-Gonzalez; Jose-Luis Fernandez-Forcelledo; Luisa-Maria Botella
Journal: Curr Vasc Pharmacol Date: 2010-07 Impact factor: 2.719

Review 8. Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia.

Authors: John J Jameson; David R Cave
Journal: Laryngoscope Date: 2004-04 Impact factor: 3.325

Review 9. Hereditary haemorrhagic telangiectasia: a clinical and scientific review.

Authors: Fatima S Govani; Claire L Shovlin
Journal: Eur J Hum Genet Date: 2009-04-01 Impact factor: 4.246

10. The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia.

Authors: Jana Simonds; Frank Miller; Jess Mandel; Terence M Davidson
Journal: Laryngoscope Date: 2009-05 Impact factor: 3.325

12 in total

Review 1. Advances in the Medical Management of Vascular Anomalies.

Authors: Kiersten W Ricci
Journal: Semin Intervent Radiol Date: 2017-09-11 Impact factor: 1.513

Review 2. Emerging role of thalidomide in the treatment of gastrointestinal bleeding.

Authors: Michael McFarlane; Lauren O'Flynn; Rachel Ventre; Benjamin R Disney
Journal: Frontline Gastroenterol Date: 2017-11-02

Review 3. Effective treatment of gastrointestinal bleeding with thalidomide--Chances and limitations.

Authors: Juergen Bauditz
Journal: World J Gastroenterol Date: 2016-03-21 Impact factor: 5.742

Review 4. Iron Deficiency and the Small bowel.

Authors: David Westrich; Christine Hachem; Christine Boumitri
Journal: Curr Gastroenterol Rep Date: 2021-07-08

5. Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study.

Authors: Rosangela Invernizzi; Federica Quaglia; Catherine Klersy; Fabio Pagella; Federica Ornati; Francesco Chu; Elina Matti; Giuseppe Spinozzi; Sara Plumitallo; Pierangela Grignani; Carla Olivieri; Raffaella Bastia; Francesca Bellistri; Cesare Danesino; Marco Benazzo; Carlo L Balduini
Journal: Lancet Haematol Date: 2015-10-27 Impact factor: 18.959

10. Thalidomide for the Treatment of Gastrointestinal Bleeding Due to Angiodysplasia in a Patient with Glanzmann's Thrombasthenia.

Authors: Bruno K L Duarte; Sílvia M de Souza; Carolina Costa-Lima; Samuel S Medina; Margareth C Ozelo
Journal: Hematol Rep Date: 2017-06-15

Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide.

1. Using thalidomide in a patient with epithelioid leiomyosarcoma and Osler-Weber-Rendu disease.

2. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.

3. Deep vein thrombosis induced by thalidomide to control epistaxis secondary to hereditary haemorrhagic telangiectasia.

Review 4. Hereditary hemorrhagic telangiectasia: from molecular biology to patient care.

5. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.

Review 6. Hereditary haemorrhagic telangiectasia.

Review 7. A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT).

Review 8. Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia.

Review 9. Hereditary haemorrhagic telangiectasia: a clinical and scientific review.

10. The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia.

Review 1. Advances in the Medical Management of Vascular Anomalies.

Review 2. Emerging role of thalidomide in the treatment of gastrointestinal bleeding.

Review 3. Effective treatment of gastrointestinal bleeding with thalidomide--Chances and limitations.

Review 4. Iron Deficiency and the Small bowel.

5. Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study.

Review 6. Therapeutic effects of thalidomide in hematologic disorders: a review.

Review 7. Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia.

Review 8. Optimal management of hereditary hemorrhagic telangiectasia.

Review 9. Epistaxis in hereditary hemorrhagic telangiectasia: an evidence based review of surgical management.

10. Thalidomide for the Treatment of Gastrointestinal Bleeding Due to Angiodysplasia in a Patient with Glanzmann's Thrombasthenia.

Review 4. Hereditary hemorrhagic telangiectasia: from molecular biology to patient care.

Review 6. Hereditary haemorrhagic telangiectasia.

Review 7. A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT).

Review 8. Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia.

Review 9. Hereditary haemorrhagic telangiectasia: a clinical and scientific review.

Review 1. Advances in the Medical Management of Vascular Anomalies.

Review 2. Emerging role of thalidomide in the treatment of gastrointestinal bleeding.

Review 3. Effective treatment of gastrointestinal bleeding with thalidomide--Chances and limitations.

Review 4. Iron Deficiency and the Small bowel​.

Review 6. Therapeutic effects of thalidomide in hematologic disorders: a review.

Review 7. Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia.

Review 8. Optimal management of hereditary hemorrhagic telangiectasia.

Review 9. Epistaxis in hereditary hemorrhagic telangiectasia: an evidence based review of surgical management.

Review 4. Iron Deficiency and the Small bowel.